ClinicalTrials.Veeva

Menu

Recovery and Symptom Relief Following Percutaneous Ablation of Abdominal Wall Endometriosis

Mayo Clinic logo

Mayo Clinic

Status

Invitation-only

Conditions

Endometriosis

Study type

Observational

Funder types

Other

Identifiers

NCT06268951
23-005485

Details and patient eligibility

About

To determine the characteristics of recovery and symptom relief following ablation of abdominal wall endometriosis.

Full description

The purpose of this study is to characterize the recovery and symptom relief following cryoablation of abdominal wall endometriosis. Patients undergoing clinically indicated ablation of abdominal wall endometriosis will receive an endometriosis-specific symptom survey (Endometriosis Health Profile - 30) prior to ablation and then at 3-, 6-, 12-, and 24-months following treatment. A 2 question survey related to pain at the treatment site will also be administered prior to ablation and then at 1-, 7-, and 30-days after ablation.

Enrollment

50 estimated patients

Sex

Female

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Undergoing ablation for abdominal wall endometriosis.

Exclusion criteria

  • Decline to participate in research.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems